Medical Cannabis & Pharmaceuticals: Growth & Disruption in U.S. Healthcare


Valued at $499

Included with a Subscription to Equio®

 Want the full report? 

Already a subscriber?  Login


New Frontier Data’s latest report delivers an in-depth and comprehensive assessment of medical cannabis preferences and behaviors, consumer purchasing and consumption habits, and the potential impact on the prescription pharmaceutical industry.


Some Key Report Findings: 

  • Growth of Medical Cannabis: The medical cannabis market is projected to almost double to over $16 billion by 2025.
  • Medical Market Intelligence: Nearly half of medical consumers (45%) identify smokable cannabis as their preferred product form while 24% prefer edibles and beverages, key insight for retailers and operators.
  • Cannabis as an Alternative for Prescription Drugs:  Leading prescription types replaced by medical cannabis include anticonvulsants (72%), glaucoma medication (71%), anti-migraine medication (65%), nausea suppressants (65%), and ADD/ADHD (62%).